Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis.

Trial Profile

Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Sep 2012

At a glance

  • Drugs Olopatadine (Primary)
  • Indications Perennial allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors Alcon
  • Most Recent Events

    • 16 Nov 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 16 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Jan 2010 Planned end date changed from 1 Jan 2011 to 1 Jan 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top